Abstract. We describe methods used and some results in a study of schizophrenia in a population of affected and unaffected participants, called patients and controls. The subjects are characterized by diagnosis, genotype, brain anatomy (MRI), laboratory tests on blood samples, and basic demographic data. The long term goal is to identify the causal chains of processes leading to disease. Methods used in this preliminary phase are statistical model building with randomization tests for p-value computations, FDR error rate control, Bayesian model comparisons, and conventional visualization. We describe preliminary findings of the study, which confirm earlier results on deviations of brain tissue volumes in schizophrenia patients, and also indicators of other effects that are presently under further investigation.
Introduction
Mental disorders account for a very significant part of total disability in all societies. In particular, every large human population in all parts of the world shows an incidence of schizophrenia between 0.5% and 1.3%. As for other mental disorders, the cause of the disease is not known, but it has been statistically confirmed that genetic factors and environmental factors before, during and immediately after birth affect its incidence. There is no treatment that cures the disease, but there is effective medication for 60-70% of the patients against the more serious symptoms. Nevertheless, schizophrenia usually leads to life-long disability at great cost for the affected individuals and their families as well as for society.
The HUBIN [13] multi-project is a set of projects aimed at understanding the mechanisms behind mental disorders and in particular schizophrenia. Despite the statement above that the cause of schizophrenia is not known, there are several current and serious hypotheses [3, 19] . These center around the development of the neuronal circuitry before birth and during childhood. This development is assumed to be influenced by factors such as genotype, infections and stress, psychology and social stimulus. The signs of this development can be seen in the journals of maternity wards, in neuropsychological tests, psychiatric assessments, the structure and sizes of the anatomical parts of the brain, and laboratory tests for substances and metabolites in blood samples. The detailed development of the disease varies a lot between patients, and only experienced psychiatrists can distinguish it from other mental disorders.
In this note, some preliminary results and methodological issues are discussed.
Data acquisition
The participants included in the study are affected patients with schizophrenia and controls. Each individual has given written consent to participate as regulated by Karolinska Institutet and the 1964 Helsinki Declaration. Exclusion criteria were conditions like drug and alcohol abuse, history of cancer, organic brain disease or brain trauma, as well as metal depositions in the body for Magnetic Resonance Imaging (MRI) investigations. Affected individuals were schizophrenia patients recruited from the northern Stockholm region. The control group was recruited from the same region and matched to the affected group with respect to age and gender. All participants underwent interview by an experienced psychiatrist to confirm schizophrenia in the affected group and absence of mental disorders in the control group.
For a set of genes believed to be important for systems possibly disturbed in persons developing schizophrenia, most of the participants were genotyped from blood samples using single nucleotide polymorphisms (SNP:s). This characterization was obtained using the pyrosequencing method [2] .
Participants were investigated in a high-resolution 1.5 T GE Signa MR scanner using a standard protocol (giving T1 and T2 weighted images with resolution of 1.5 mm). This protocol admits reliable discrimination of the main brain tissues grey and white matter and cerebro-spinal fluid (CSF), as well as venous blood and other tissue or air. A more detailed description of MR data acquisition can be found in [1] .
Blood samples were obtained in which the concentration of certain substances and metabolites are measured with standard laboratory tests. Standard demographic data were obtained, like gender, handedness, month of birth, age and age at first admittance for psychiatric care for the patients.
Data analysis
The long term goal is to understand the causal chains leading to the disease. Presently, the data acquired is probably not enough, neither in volume nor in number of variables measured, to give the final answer to this question, but associations in the data are important clues.
The most voluminous part of the data is structural MRI information. The MR scans were converted to 3D images and processed by the BRAINS software developed at University of Iowa [4, 22] . After manual location of landmarks, the scans are mapped into a standard Talairach space by a linear transformation. Each voxel is classified as white, gray, CSF, blood or other, and the volume of white and gray matter as well as CSF are obtained by voxel counting in a number of regions defined as unions of Talairach boxes: The cerebrum is the union of a number of box sets delineating the frontal, temporal, parietal, occipital and subcortical regions. Other volumes measured are the ventricular region, brainstem and cerebellum. The volumes of white, gray and wet in each region is a variable whose name is the region name prefix followed by the content type, like VenGray, CerWhite, BrsCSF, etc.. A suffix A or R indicates absolute (ml) values or values relative to the individuals intracranial volume. A number of anatomically distinguishable regions in the vermis of cerebellum (posterior inferior (PIV), posterior superior (PSV), and anterior (AV) vermis) and the cerebellar hemisphere(CH) were manually traced and measured (volume only). The reason for including the vermis region is that it is involved in control of eye movements, which are atypical for persons with schizophrenia. These data have been previously analyzed for a limited number of male participants [17] . In the data used here, there are 144 participants with 30 brain region variables given both in absolute value (ml) and relative to intracranial volume, six summary brain size measures (total volume of discriminated tissue/fluid types), 5 manually measured cerebellar volumes (with absolute and relative values), 58 blood test variables, 7 genetic (SNP) variables 8 demographic variables, besides the diagnosis, making altogether 140 variables. For some of these there are missing values, which can be regarded as missing completely at random.
It is well known from previous studies that there is no single anatomical or physiological variable that directly predicts the disease with high confidence, but it is also known that many variables are statistically associated with the disease [23] . Presently, the goal is to find tentative answers to the following questions:
-For which variables is there a significant difference between affected and controls? -For which pairs (triples, etc.) of variables is there a significant difference in co-variation between patients and controls? -Is it possible to predict diagnosis from a participants physiological data? -Is it possible to find, in the data, different types of the disease?
It has been assumed from the start of this project that modern data mining technology would 'find' the answers. However, the answers to the above questions cannot be found easily by just assuming 'enough' data is there, because this is not the case. So there is still a significant statistical component in the investigation. On the other hand, once an effect has been considered significant, the best way to communicate the nature of the effect is typically as a graph.
The two basic approaches possible are tests and Bayes factors. In the first, a null hypothesis and a test statistic is chosen, a p-value is computed and used to reject the null hypothesis if possible. In the second approach, a Bayes factor is computed which tells to what degree the test data support the hypothesis of no association relative to a composite hypothesis of association. The multiple testing effect is taken care of by suitable choice of prior odds. We have chosen not to assume particular distributions for the variables, since the resulting tests and model selections would be distorted by deviations It would of course be valuable if the recently developed methods to find causal links in the data are applicable. Testing our data against a number of different methods for finding causal links [18, 12] , it turned out that in several instances the participants age, month of birth and genotype came out as caused by the phenotype, e.g., the size of a part of the brain would have been a cause of the persons DNA variant. This is highly unlikely to be correct, since the genotype is determined at time of conception, before the development of the individual starts. This finding was not completely unexpected, and confirms our belief that the variables presently measured do not include all important information needed to ultimately explain the disease, and also that there may be some important bias in selection. Our study is thus oriented somewhat humbly to finding fragments of the processes leading to disease.
Association tests based on randomizations
The general test method is as follows: We investigate the null hypothesis that the diagnosis was determined at random after the variables were measured. A test statistic was chosen giving a 'difference' between affected and controls, and its value for the data was compared to the cumulative distribution of the test statistics from 100 000 random assignments of the diagnosis (in the same proportion as in the original data [11] ). The p-value obtained is the proportion of more extreme test statistics occurring in the randomized data. As test statistics for single variables we chose the difference between affected and controls in mean and variance. For pairs of variables we normalize the variables and find the absolute value of the cosine between the directions, for patients and for controls, of largest variation, which is used as test statistic.
Multiple comparison considerations
The p-values obtained show what the significance would be if the corresponding test was the only one performed. However, since many variables and variable pairs were tested, one would expect the tables of significant effects to contain hundreds of spurious entries.
In family-wise error control (FWE [15] ), one controls the probability of finding at least one erroneous rejection. A Bonferroni correction divides the desired significance, say 5%, with the number of tests made, and the p-values below this value are stated as significant. More sophisticated approaches are possible.
A recent proposal is the control of false discovery rate [6] . Here we are only concerned that the rate (fraction) of false rejections is below a given level. If this rate is set to 5%, it means that of the rejected null hypotheses, on the average no more than 5% are falsely rejected. It was shown that if the tests are independent or positively correlated in a certain sense, one should truncate the rejection list at element k where k = max{i : p i ≤ qi/m}, and p i is the ordered list of p-values. This cut-off rule will be denoted FDRi.
If we do not know how the tests are correlated, it was also shown in [7] that the cut-off value is safe if it is changed from qi/m to qi/(mH m ), where
This rule is denoted FDRd. The most obvious correlations induced by the testing in our application plan satisfy the criterion of positive (monotone) correlation of [7] . A new idea in multiple comparison evaluation is the q-value, which can be seen as putting frequentist comparisons in a Bayesian context [21] . The idea is to estimate, for a set of p-values, the probability of false rejection for each, dependent on the whole set of p-values obtained and estimates of interdependency of tests. Apparently, a very large number of 'probably significant' associations exist, most of which were pruned by the FDRd test. In application terms, one could say that the disease interacts globally with the development of the brain and permeates into every corner of it. In order to obtain a reasonable amount of clues, we must obviously consider how to find the most important effects. This is a common concern analyzing large and disparate statistical data sets obtainable with modern technology. A standard way to approach the problem is to use linear or generalized linear models. Another proposal is that maybe Bayes factors are better indicators than p-values [16] of effects. The question is not settled, but let us try the Bayesian method and see what we get:
Bayesian association determination
The Bayesian paradigm does not work by rejecting a null hypothesis, but compares two or more specific hypotheses. In our case, hypotheses are compared for each possible association, and the relative support the data give them are summarized as Bayes factors for one against the rest. We have not given detailed prior probabilities to the hypotheses. We can check for multiple testing effects by introducing costs for the two types of error possible. This will have exactly the same effect as a prior probability promoting the null hypothesis. We have penalized for mass testing by giving low prior odds for the dependency hypothesis, so that on the whole our prior information is that on the average only one of the variables should be dependent on the diagnosis.
The hypotheses in this case are that the same distribution generated the variables for affected and controls, and that two different distributions generated them, respectively. As distribution family we take piece-wise constant functions, which translates to discretization of the variables. The prior distribution over the family is taken to be a Dirichlet distribution. Then the standard association tests of discrete distributions used e. g. in graphical model learning [5, 14] are applied. An empirical Bayes approach is used, where the granularity is chosen to give a sufficient number of points in each discretization level.
Bayesian association models
For a chosen discretization, a variable will be described as an occurrence vector
, where d is the number of levels and n i is the number of values falling in bin i.
be the probability vector, x i being the probability of a value falling in bin i. A Bayesian association test for two variables is a comparison of two hypotheses, one H d in which the variables are jointly generated and one H i in which they are independently generated. Table 2 . Bayesian association (log Bayes factor), variable to diagnosis. Strongly associated variables are brain regions, but also serum triglycerides (S TG K1). Table 2 gives the log Bayes factors, log(p(n|H d )/p(n|H i )), of H d against H i for variables discretized into 5 levels. Assuming the previously mentioned prior, entries with log Bayes factor above 2 would be deemed significant.
For the co-variation investigation we chose to compare the eight undirected graphical models on triples of variables, one of which is the diagnosis. high posterior probability, then this means that the variation of the data cannot be described as resulting from influence of the diagnosis on one of the two variables or as independent influence on both -the association between the variables is different for affected and controls. In figure 1 , the left graph represents the type of co-variation we are looking for. The next graph explains data as the diagnosis D affecting variables A and B separately, whereas the rightmost graph describes a situation where the association between A and B is similar for affected and controls. The variables were also standardized, separately for affected and controls to minimize influence of differences in single variable distributions.
In both frequentist and Bayesian pairwise variable association studies, the posterior superior vermis (PSV) was highly linked via the diagnosis to several other variables. Particularly interesting is the age variable, which is known to be independent ( figure 2(b) ). For controls, the PSV volume decreases with age, but for patients the PSV is smaller and not dependent on age. Bayesian association estimates are the basis for graphical models describing co-variation of variable sets. In this respect they are similar to generalized linear models [8] . Based on the strength of pairwise variable associations, decomposable graphical models were obtained from the data matrix. For the matrix containing demographic, physiology and automatically measured white, gray and CSF volumes, and genotype, the central part of the model was found to be as shown in figure 3(a) . In words, the diagnosis is most distinctly, in statistical terms, associated with the CSF volumes in the brainstem and temporal regions.
Even more closely associated are the vermis regions that were measured manually (volumes only). When the vermis variables are also included, the model looks like figure 3(b) . The position of the temporal CSF variable in the diagram suggests that a brain region affected similarly to the vermis can be located in the temporal boxes. 
Genetics data
The genetic variables were not strongly associated to phenotype variables measured. This does not mean that they are uninteresting. The basic machinery of biological systems is run by proteins, and the genes are blueprints of these proteins. The different variations, alleles, of a gene result in small variations in the proteins they produce. For single gene diseases there is often a single variation of the protein that immediately leads to the disease, but for multiple gene diseases, to which schizophrenia apparently belongs, there is a whole family of genes with variants that have small effects on the disposition for disease, in other words they push the whole organisms development slightly in the direction where the etiology of disease can begin to unfold. The complexities of these processes are overwhelming, and although a large amount of knowledge has been accumulated over a few decades, it is fair to say that even more is presently unknown. The SNP genotyping separates the alleles of a gene into two classes, and these two classes can be slightly different in function of the protein and its effect on the development of an individual. By finding associations between genotype and other variables, information about the role of the corresponding protein and its metabolites in development can be extracted. Because of the weakness of the statistical signals, genetics data must be examined with the most powerful statistical methods available.
The informative genes and their polymorphisms measured for the population are shown in A/G 5 37 80 brain derived neurotrophic factor Table 3 . Genes with informative SNP:s.
A Bayesian comparison with the diagnosis variable speaks weakly in favor of independence between genotype and diagnosis for all polymorphisms available. The same is true when using Fishers exact test. But we have also many other variables related to brain development. Testing the genes against all variables, 63 p-values below 5% were found. However, applying the FDRd or FDRi correction on 5% false rejection rate, none of these survive. It is somewhat remarkable, however, that 30 small p-values are related to the polymorphism in the BDNF gene. There is thus ground for the suspicion that this polymorphism has a visible influence on brain development. It is possible to state this influence in statistical terms: in the FDR sense, on the average 80% of 30 variables are affected by this polymorphism. Among these variables are the manually traced posterior inferior vermis, gray matter in the frontal, parietal, subcortical, temporal and ventricular regions, as well as the B-MCV-01 and S-LDL-B1 (mean corpuscular volume and serum low density lipoproteins) blood tests.
Some of the strongest associations found are shown in figure 4 . In summary, the current genetics data show that there are likely genetic dependencies of variables, but the statistical power is not yet adequate to identify specific associations with high significance.
Prediction and classification study
It is a known difficult problem to determine the diagnosis of schizophrenia from physiological variables. We checked that this is also the case for our data sets. Supervised classifiers were built using both support vector [10] and decision tree [5] techniques. When trained on random samples of 75% of the participants and tested on the remaining individuals, a classification accuracy of approximately 78% was obtained. As a comparison, the optimal discriminating single variable, PSV, gives a 75% correct classification on the set (were it is used both for training and testing, see figure 2(a) ). Another technique that has been useful is unsupervised classification. Classifications of schizophrenia patients have usually been performed with cluster analysis paradigms [20] . The AUTOCLASS paradigm instead tries to find classifications with high probability, under assumptions of particular distributions for the variables within each class. We ran the AUTO-CLASS software [9] on a subset of participants and variables without missing values. The variables where assumed to be independent, categorical or normally distributed within each class. AUTOCLASS searches for the classification in the form of a probability mixture with maximal probability of generating the data. In our case, a four class mixture was identified for the population consisting of 42% affected. The most important variable for the classification was total (absolute) volume of gray matter. One of the classes has mainly (75%) controls and a high value for gray matter. The next class has a high proportion of patients (83%), somewhat less but dispersed (high variance) gray matter. A third class has the same amount of gray matter, but with low variance and not very discriminated wrt diagnosis (33% affected). The final class has low volume of gray matter and 34% affected. Other classification approaches are presently under investigation.
We have confirmed a number of previous findings, particularly the important role of the cerebellar vermis in schizophrenia [17] , and identified a number of interesting associations that suggest more detailed investigations, e.g., of the role of the BDNF gene and the detailed anatomy of temporal and other regions of the brain. More definitive results are expected when more detailed data from other domains can be included, because then it should be possible to construct some causality conclusions from the observational data -genetic and environmental factors lie before those we have investigated, and psychiatry data should lie after in the causal chains.
On the methodological side, it is clear that the data mining philosophy implies making a large number of tests and similar investigations involving both p-values, Bayesian model comparisons and visual inspections. It is also obvious that these three methods complement each other -testing is appropriate when the null hypothesis can be precisely formulated and then for any test statistic randomization tests can give a p-value, the classical risk that an erroneous conclusion is drawn. But Bayesian model comparison is a very natural and easily implemented method that gives answers when there is no obvious null hypothesis. Bayes factors are also -at least in this study -better indicators of effects than p-values. Lastly, graphical visualizations are necessary as confirmations of statistical effects.
The strict control of multiple comparison effects can not easily be formalized in typical data mining since many investigations are summarily discarded for lack of obvious effects or lack of interest from application experts. Our method must make an intricate balance between creation of significance and creation of sense -without inventing an implausible story. This is a problem that seems not yet fully addressed, neither in the statistics nor in the data mining communities. Some further development of the q-values proposed by Storey [21] might be useful for this purpose
